Switzerland is home to a highly innovative life science cluster. Many multinational corporations, as well as a network of smaller companies and startups have operations in Switzerland, mostly in the Basel Area.
In China, the life science industry has been growing at an accelerated pace and brings a growing number of innovative drugs and services to the European market.
We're diving into how Swiss and Chinese pharmaceutical companies team up to succeed in a changing world. Plus, we'll explore how biopharma companies get the support they need in both China and Switzerland. Learn all about expanding into new markets and investing in promising start-ups.
Guest speakers from Swiss as well as Chinese companies will present insights into the following topics:
- Unleashing innovation: Set up operations in Switzerland to foster partnerships between Swiss and Chinese biopharma companies.
- Building bridges: Discover infrastructure support for biopharma pioneers in both nations.
- Expanding horizons: Navigate market changes and unlock investment potential for startups.
Come join us as we connect with colleagues from Switzerland and China to explore new possibilities in the changing world of life sciences.
Organizers
Sponsors
Programm Details
Mr. Christian Wyss, Partner, VISCHER
Ms. Anke Hollnagel, Director Asia, Basel Area Business & Innovation
Dr. Jiansong Yang, Ms. Xi Zhang, Mr. Bruno Delie, Ms. Lin Jin
Mr. Christian Wyss, Partner, VISCHER
Ms. Anke Hollnagel, Director Asia, Basel Area Business & Innovation
Dr. Jiansong Yang
Chief Scientific Officer at Tigermed
Dr. Jiansong Yang serves as the Chief Scientific Officer at Tigermed, a global Contract Research Organization (CRO) and the largest clinical CRO in China. Before joining Tigermed, he held the position of Founder and CEO at Mosim, which is now part of Tigermed. At Mosim, Dr. Yang led a team of over 100 scientists, focusing on early clinical services, including drug development strategy, clinical study design, and PK/PD data analysis.
With more than 20 years of experience in the pharmaceutical industry, Dr. Yang specializes in early drug development and clinical study design. Prior to founding Mosim, he served as the Director of Clinical Pharmacology at GSK. He earned his Ph.D. in Clinical Pharmacokinetics from the University of Sheffield, UK.
Please click HERE for registration. You will be redirected to our cooperation partner Basel Area.
This event is organized by the Swiss-Chinese Chamber of Commerce, in cooperation with Basel Area and VISCHER.